Woodland International Research Group, LLC ( Site 1002) — Little Rock, Arkansas

Woodland International Research Group, LLC ( Site 1002) is a clinical research site located in Little Rock, Arkansas, United States 72211.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

Woodland International Research Group, LLC ( Site 1002) has participated in 1 clinical trials.

Therapeutic areas: Schizophrenia.

Sponsors: Merck Sharp & Dohme LLC.

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Woodland International Research Group, LLC ( Site 1002)?

Woodland International Research Group, LLC ( Site 1002) has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Woodland International Research Group, LLC ( Site 1002) conducted?

Woodland International Research Group, LLC ( Site 1002) has 1 clinical trials on record. Their work covers Schizophrenia.

Is Woodland International Research Group, LLC ( Site 1002) accredited by Crixeo Health?

Woodland International Research Group, LLC ( Site 1002) has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Woodland International Research Group, LLC ( Site 1002)?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.